Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Jønch, Aia E ^a   Danielsen, Else R ^a   Thomsen, Carsten ^a   Meden, Per ^b   Svenstrup, Kirsten ^a,c   Nielsen, Jørgen E ^a,c  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adrenomyeloneuropathy; IVIG treatment; Limb pain; Magnetic resonance spectroscopy

Indexed keywords

ABCD1 PROTEIN; CHOLINE; CHROMOSOME PROTEIN; HISTIDINE; IMMUNOGLOBULIN; N ACETYLASPARTIC ACID; TESTOSTERONE; TYROSINE; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BABINSKI REFLEX; CASE REPORT; CORTICOTROPIN TEST; FATTY ACID BLOOD LEVEL; GENE MUTATION; HEAT SENSATION; HUMAN; HYPERREFLEXIA; LEG MUSCLE; LEG PAIN; LIBIDO DISORDER; MALE; MUSCLE HYPOTONIA; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; PARESTHESIA; PATIENT REFERRAL; SENSORY NERVE CONDUCTION; SPASTIC PARAPLEGIA; TENDON REFLEX; TESTOSTERONE BLOOD LEVEL; VIBRATION SENSE;

ADRENOLEUKODYSTROPHY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84870658768     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-108     Document Type: Article

References (10)

1. Moser HW. Therapy of X-linked Adrenoleukodystrophy. NeuroRx 2006, 3(2):246-253. 10.1016/j.nurx.2006.01.004, 16554262.
2. Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: A neuropathologic review featuring its noninflammatory myelopathy. J neuropathol Exp Neurol 2000, 59(2):89-102.
3. Van Geel BM, Bezman L, Loes DJ, Mose HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 2001, 49:189-194.
4. Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M. Spectroscopic evidence of cerebral axonopathy in patients with " pure" adrenomyeloneuropathy. Neurology 2005, 64:304-310. 10.1212/01.WNL.0000149514.13580.84, 15668429.
5. Berger J, Pujol A, Aubourg P, Forss-Petter S. Current and future pharmacological strategies in X-linked adrenoleukodystrophy. Brain Pathol 2010, 20(4):845-856. 10.1111/j.1750-3639.2010.00393.x, 2967711, 20626746.
6. Vinik AI, Anandacoomaraswamy D, Ullal J. Antibodies to neuronal structures. Innocent bystanders or neurotoxins?. Diabetes Care 2005, 28(8):2067-72. 10.2337/diacare.28.8.2067, 16043764.
7. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006, 52(1):77-92. 10.1016/j.neuron.2006.09.021, 1810425, 17015228.
8. Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Evidence-based indications and safety profile. Pharmacol Ther 2004, 102(3):177-93. 10.1016/j.pharmthera.2004.04.002, 15246245.
9. Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. J Neurol Sci 2009, 279(1-2):57-61.
10. Kawagashira Y, Watanabe H, Oki Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry 2007, 78(8):899-901. 10.1136/jnnp.2006.111302, 2117752, 17635982.